课题基金 / 基金详情

Effect of 18 Months of Teriparatide Therapy on Bone Microarchitecture and Bone Volume in Postmenopausal Women with Osteoporosis

Effect of 18 Months of Teriparatide Therapy on Bone Microarchitecture and Bone Volume in Postmenopausal Women with Osteoporosis
18个月特立帕肽治疗对绝经后骨质疏松症女性骨微结构和骨量的影响
批准号:
176104
负责人:
Cheung Angela M
金额:
$5.65万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-09-01 至 2009-09-01

项目摘要

项目成果

Cheung Angela M的其他基金

相关文献

中文摘要
翻译
临床试验表明,骨形成药物Teriparatide在治疗20个月后增加了腰椎和全髋部的骨密度(BMD),但降低了前臂的BMD。目前尚不清楚福克斯的骨密度下降是否
英文摘要
Clinical trials have shown that teriparatide, a bone formation drug, increases bone mineral density (BMD) at the lumbar spine and total hip, but decreases BMD at the forearm after 20 months of therapy. It is unclear whether this decrease in BMD at the fo
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)
  • 批准号:
    466274
  • 项目类别:
    Operating Grants
  • 资助金额:
    $314.29万
  • 财政年份:
    2022
  • 负责人:
    Cheung Angela M
  • 依托单位:
Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)
  • 批准号:
    481153
  • 项目类别:
    Operating Grants
  • 资助金额:
    $78.57万
  • 财政年份:
    2022
  • 负责人:
    Cheung Angela M
  • 依托单位:
Long COVID Web: Pan-Canadian Post-COVID Condition Research Network
  • 批准号:
    474666
  • 项目类别:
    Operating Grants
  • 资助金额:
    $1456.97万
  • 财政年份:
    2022
  • 负责人:
    Cheung Angela M
  • 依托单位:
The RECLAIM (REcovering from COVID-19 Lingering symptoms Adaptive Integrative Medicine) trial
  • 批准号:
    448867
  • 项目类别:
    Operating Grants
  • 资助金额:
    $72.85万
  • 财政年份:
    2021
  • 负责人:
    Cheung Angela M
  • 依托单位: